Supernus Pharmaceuticals Inc (SUPN) Company Report March 01, 2023, 01:15 UTC 51 New Form 8-K for Supernus Pharmaceuticals Comment Full text
Nektar Therapeutics (NKTR) Company Report March 01, 2023, 01:14 UTC 52 New Form 10-K for Nektar Therapeutics Comment Full text
Pacific Biosciences of California Inc (PACB) Company Report March 01, 2023, 01:05 UTC 44 New Form 10-K for Pacific Biosciences of California Inc Comment Full text
Novavax Inc (NVAX) Company Report March 01, 2023, 00:55 UTC 41 New SEC Filing for Novavax Inc. (NASDAQ:NVAX) Comment Full text
Avidity Biosciences Inc (RNA) Company Report March 01, 2023, 00:54 UTC 44 New SEC Filing for Avidity Biosciences Inc. (NASDAQ:RNA) Comment Full text
Revance Therapeutics (RVNC) Company Report March 01, 2023, 00:39 UTC 43 New Form 10-K for Revance Therapeutics, Inc. Comment Full text
Syndax Pharmaceuticals Inc (SNDX) Company Report March 01, 2023, 00:20 UTC 49 New Form 10-K for Syndax Pharmaceuticals, Inc. Comment Full text
Fate Therapeutics Inc (FATE) Company Report March 01, 2023, 00:20 UTC 46 New Form 10-K for Fate Therapeutics, Inc. Comment Full text
Agilent Technologies Inc. (A) Company Report March 01, 2023, 00:11 UTC 46 Agilent Technologies, Inc. - First Quarter 2023 Comment Full text
Castle Biosciences Inc (CSTL) Company Report March 01, 2023, 00:10 UTC 48 Castle Biosciences - Fourth Quarter 2022 Comment Full text